COVID-19-associated venous thromboembolism: risk of recurrence and major bleeding.

ABSTRACT:

Background

Complications under anticoagulant treatment in patients with COVID-19-associated venous thromboembolism (VTE) have not been consistently reported.

Objectives

This study aimed to compare the 90-day rates of VTE recurrences and major bleeding in patients with COVID-19-associated VTE versus those with VTE without COVID-19.

Methods

We used the RIETE registry to compare the 3-month outcomes in patients with COVID-19-associated VTE versus those with VTE without COVID-19.

Results

The study included 1,747 patients with COVID-19-associated VTE and 8,711 with VTE without COVID-19. Patients with COVID-19-associated VTE were more likely to be hospitalized at baseline and to present with pulmonary embolism. During the first 90 days, 123 patients (1.17%) developed

SUBMITTER: Demelo-Rodriguez P 

PROVIDER: S-EPMC10569976 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature